DEZAWA MUSE SECRETOMES
LIVE

Serial Number

99721405

Owner

MUSECELL INNOVATIONS PTE. LTD.

Attorney

Betsy Wang Lee

Filing Date

Mar 24, 2026

Add to watchlist:

No watchlists yet
View on USPTO

DEZAWA MUSE SECRETOMES Trademark

Serial Number: 99721405

DEZAWA MUSE SECRETOMES is a trademark filed by MUSECELL INNOVATIONS PTE. LTD. on March 24, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

MUSECELL INNOVATIONS PTE. LTD. (66 trademarks)

20 COLLYER QUAY,

Entity Type: 24

Trademark Details

Filing Date

March 24, 2026

Registration Date

Not Registered

Goods & Services

Cells for medical purposes; Cells for medical use; Cellular function activating agents for medical purposes; Cellulose esters for pharmaceutical purposes; Cellulose ethers for pharmaceutical purposes; Cellulose for pharmaceutical purposes; Chemicals for cell separation and cultivation for medical or veterinary purposes; Chemicals for separating and cultivating cells for medical or veterinary purposes; Living cells for medical purposes; Living cells for medical use; Pharmaceutical compositions containing stem cells for the treatment of diseases; Pharmaceutical preparations containing stem cells; Pharmaceutical preparations for activating cellular function; Stem cells for medical purposes; Autoinjectors prefilled with pharmaceutical preparations; Immunological products for intravenous injections; Injectable medicinal solutions; Injectable solutions for medical purposes; Injectable solutions for use in inhibiting peristalsis for medical purposes; Pharmaceutical preparations sold in pre-filled injectors; Intravenous fluids used for the delivery of pharmaceutical preparations; Intravenous solutions for medical purposes; Immunosuppressive pharmaceutical preparations; Pharmaceutical preparations for the treatment of cystic fibrosis; Glycerophosphates; Phosphates for pharmaceutical purposes; Cardiovascular agents for medical purposes; Cardiovascular pharmaceutical preparations; Cardiovascular pharmaceuticals; Cardiovascular preparations; Cardiovascular treatment preparations; Drugs for the treatment of cardiovascular diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations and substances for the prevention of cardiovascular diseases and disorders; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; Pharmaceutical preparations for the prevention of cardiovascular disorders; Pharmaceutical preparations for the treatment of cardiovascular disease; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations for treating cardiovascular diseases; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Anti-ulcer agents; Pharmaceutical preparations being antiulceratives; Pharmaceutical preparations for the treatment of chronic liver diseases; Engineered animal biological tissues for use in regenerative medicine; Engineered human biological tissues for use in regenerative medicine; Engineered animal biological tissues for medical purposes; Engineered biological tissues for medical purposes; Engineered human biological tissues for medical purposes; Tissue-regenerative medical preparations; Tissue-regenerative pharmaceutical preparations; Veterinary preparations for equines; Medical preparations for use in the treatment of injuries; Bioresorbable grafts comprised of living tissues for use in tissue regeneration; Medicated preparations for the regeneration of the skin; Injectable pharmaceuticals; Veterinary preparations for administration by injection; Biological preparations for medical purposes; Biological preparations for pharmaceutical purposes; Biological preparations for use in biotechnology for medical or veterinary purposes; Biological preparations for use in cell cultures for medical or veterinary purposes; Biological preparations for veterinary purposes; Biological reagents for medical or veterinary purposes; Biological reagents for veterinary purposes; Biological reagents for veterinary use; Biological tissue cultures for veterinary purposes; Biomaterials in the nature of biological tissue cells for medical purposes; Biomaterials in the nature of biological tissue cultures for medical purposes; Biomaterials in the nature of biological tissues for medical purposes; Mixed biological preparations for medical purposes; Reagents for use in biological processing for veterinary purposes; Animal feed additives for use as nutritional supplements; Animal feed supplements for veterinary purposes; Delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; Delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; Dietary and nutritional supplements; Dietary nutritional supplements for medical use; Dietary supplements; Dietary supplements for animals; Dietary supplements for medical use; Dietary supplements for pets; Dietary supplements for pharmaceutical purposes; Dietary supplements for veterinary purposes; Dietary supplements intended to supplement a normal diet or to have health benefits; Dietetic food supplements; Dietetic food supplements adapted for medical purposes; Dietetic food supplements adapted for veterinary purposes; Dietetic supplements; Dietetic supplements for medical purposes; Feed supplements for veterinary use; Feed supplements for veterinary purposes; Food supplements; Food supplements for animals; Food supplements for medical purposes; Food supplements for pets; Food supplements for veterinary purposes; Food supplements for veterinary use; Nutritional supplements for animal feed; Nutritional supplements for animals; Nutritional supplements for animals for medical use; Nutritional supplements for livestock feed; Nutritional supplements for medical use; Nutritional supplements for pets; Nutritional supplements for veterinary use; Lyophilised food adapted for medical purposes; Lyophilized food adapted for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating muscle injuries and disorders; Pharmaceutical preparations for use in the treatment of muscle tension; Living tissues for use in guided tissue regeneration; Pharmaceutical preparations for assisting the prevention of bone diseases; Pharmaceutical preparations for the prevention and treatment of bone diseases; Pharmaceutical preparations for the prevention of bone conditions; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for the treatment of bone disorders; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical products for the treatment of bone diseases; Pharmaceuticals for the treatment of bone diseases; Anti-inflammatories; Anti-inflammatory agents; Anti-inflammatory gels; Anti-inflammatory preparations; Compounds having an anti-inflammatory activity; Non-steroidal anti-inflammatory drugs; Pharmaceutical preparations for the prevention of inflammatory disorders; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of inflammatory disorders; Synthetic peptides for pharmaceutical purposes; Biochemical preparations for veterinary purposes; Biochemical preparations for veterinary use; Chemicals for separating and culturing of cells for medical or veterinary purposes; Chemicals for use in analysis for medical and veterinary purposes; Clinical diagnostic preparations for medical or veterinary use; Cord blood for veterinary purposes; Cultures for veterinary use; Living cells for veterinary purposes; Living cells for veterinary use; Medicines for veterinary purposes; Stem cells for veterinary purposes; Veterinary medicaments; Veterinary preparations; Veterinary preparations and substances; Veterinary preparations for the immunisation against disease; Veterinary preparations for treatment of intestinal bacteria; Veterinary preparations for use in improving the coat; Veterinary preparations for use in improving the skin; Veterinary preparations for use in treating the coat; Veterinary preparations for use in treating the skin; Veterinary preparations in dosage forms for veterinary use; Veterinary preparations sold in pre-filled syringes

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 16, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 16, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 16, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 25, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 24, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 24, 2026 NWOS
NEW APPLICATION ENTERED
Mar 24, 2026 NWAP